Skip to main content

Press Releases and Ad-hoc Announcements

21 November 2019	AH: Heidelberg Pharma Participates in Franco-German Joint Venture Emergence Therapeutics and Signs Collaboration and License Agreement	PDF
12 November 2019	AH: Partner Magenta Therapeutics Exercises Option to Further Develop Antibody Targeted Amanitin Conjugates Targeted to CD45	PDF
07 November 2019	PR: Heidelberg Pharma Announces Participation at Various Conferences	PDF
26 October 2019	PM: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2019	PDF
11 October 2019	PM: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2019	PDF
03 October 2019	AH: Heidelberg Pharma AG Announces Adjustment of Guidance	PDF
20 September 2019	PR: Heidelberg Pharma receives European Union research grant for the ETN MAGICBULLET project	PDF
12 July 2019	PR: Heidelberg Pharma reports on first half-year	PDF
12 June 2019	PR: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences	PDF
06 June 2019	PR: Heidelberg Pharma Receives Milestone Payment from Partner Telix	PDF
22 May 2019	PR: Heidelberg Pharma Reports Outcome Of Annual General Meeting	PDF
12 April 2019	PR: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2019	PDF
28 March 2019	PR: Heidelberg Pharma to present its proprietary ATAC technology platform at the AACR Annual Meeting 2019	PDF
21 March 2019	PR: Heidelberg Pharma announces financial figures for fiscal year 2018 and provides business update	PDF
23 January 2019	PR: Heidelberg Pharma Receives Milestone Payment From Partner Link Health	PDF